Search results
Psoriasis and Depression: What’s the Connection?
Verywell Health via Yahoo News· 2 weeks agoPsoriasis is a chronic skin condition that can affect your mood, and many people with psoriasis experience depression. Here’s what you can do if you feel...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 1 week agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic...
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace· 3 days agoInvestors concerned about broader market undulations may want to consider the resilience narrative...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 2 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 2 weeks agoA number of other analysts have also recently weighed in on the company. Truist Financial raised their price objective on AbbVie from $180.00 to $195.00 and gave the stock ...
AbbVie (NYSE:ABBV) Price Target Cut to $187.00
ETF DAILY NEWS· 1 week agoBarclays‘s target price would suggest a potential upside of 14.94% from the company’s previous close. Several other equities research analysts have also recently commented on ABBV. BMO Capital ...
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 1 week agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. AbbVie traded as low as $158.56 ...